nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Primaquine—CYP1B1—esophageal cancer	0.0243	0.449	CrCbGaD
Hydroxychloroquine—Amodiaquine—CYP1B1—esophageal cancer	0.0206	0.382	CrCbGaD
Hydroxychloroquine—Pigmentation disorder—Capecitabine—esophageal cancer	0.0144	0.0319	CcSEcCtD
Hydroxychloroquine—CYP2D6—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.0138	0.0279	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—HMGB1—esophageal cancer	0.0115	0.0232	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—HMGB1—esophageal cancer	0.0113	0.0228	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0109	0.022	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—HMGB1—esophageal cancer	0.0109	0.022	CbGpPWpGaD
Hydroxychloroquine—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.0107	0.0238	CcSEcCtD
Hydroxychloroquine—Retinal disorder—Methotrexate—esophageal cancer	0.01	0.0222	CcSEcCtD
Hydroxychloroquine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00955	0.0193	CbGpPWpGaD
Hydroxychloroquine—Cardiomyopathy—Capecitabine—esophageal cancer	0.00941	0.0208	CcSEcCtD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—HMGB1—esophageal cancer	0.00908	0.0184	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—HMGB1—esophageal cancer	0.00891	0.018	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CAPZA1—esophageal cancer	0.00868	0.0176	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—HMGB1—esophageal cancer	0.0086	0.0174	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—CYP2E1 reactions—CYP2A6—esophageal cancer	0.00854	0.0173	CbGpPWpGaD
Hydroxychloroquine—Leukoderma—Methotrexate—esophageal cancer	0.00843	0.0187	CcSEcCtD
Hydroxychloroquine—Visual acuity reduced—Capecitabine—esophageal cancer	0.0081	0.0179	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—HMGB1—esophageal cancer	0.00773	0.0156	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00731	0.0148	CbGpPWpGaD
Hydroxychloroquine—Appetite absent—Methotrexate—esophageal cancer	0.00721	0.016	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Capecitabine—esophageal cancer	0.00713	0.0158	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CAPZA1—esophageal cancer	0.00686	0.0139	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TMEM173—esophageal cancer	0.00686	0.0139	CbGpPWpGaD
Hydroxychloroquine—Hearing impaired—Cisplatin—esophageal cancer	0.00686	0.0152	CcSEcCtD
Hydroxychloroquine—Pain—Carboplatin—esophageal cancer	0.0068	0.015	CcSEcCtD
Hydroxychloroquine—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00673	0.0136	CbGpPWpGaD
Hydroxychloroquine—Throat sore—Capecitabine—esophageal cancer	0.00668	0.0148	CcSEcCtD
Hydroxychloroquine—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.00662	0.0147	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Cisplatin—esophageal cancer	0.00653	0.0145	CcSEcCtD
Hydroxychloroquine—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00633	0.0128	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Carboplatin—esophageal cancer	0.00628	0.0139	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TLR4—esophageal cancer	0.00628	0.0127	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—HMGB1—esophageal cancer	0.00611	0.0124	CbGpPWpGaD
Hydroxychloroquine—Eruption—Methotrexate—esophageal cancer	0.00583	0.0129	CcSEcCtD
Hydroxychloroquine—Psoriasis—Methotrexate—esophageal cancer	0.0057	0.0126	CcSEcCtD
Hydroxychloroquine—Contusion—Capecitabine—esophageal cancer	0.00552	0.0122	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TMEM173—esophageal cancer	0.00543	0.011	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—CASP8—esophageal cancer	0.00539	0.0109	CbGpPWpGaD
Hydroxychloroquine—Skin discolouration—Capecitabine—esophageal cancer	0.00533	0.0118	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Methotrexate—esophageal cancer	0.00531	0.0118	CcSEcCtD
Hydroxychloroquine—Deafness—Cisplatin—esophageal cancer	0.0053	0.0117	CcSEcCtD
Hydroxychloroquine—Oropharyngeal pain—Capecitabine—esophageal cancer	0.0053	0.0117	CcSEcCtD
Hydroxychloroquine—CYP2D6—Xenobiotics—CYP2A6—esophageal cancer	0.00529	0.0107	CbGpPWpGaD
Hydroxychloroquine—Liver disorder—Methotrexate—esophageal cancer	0.00526	0.0116	CcSEcCtD
Hydroxychloroquine—Paralysis—Methotrexate—esophageal cancer	0.00516	0.0114	CcSEcCtD
Hydroxychloroquine—CYP2D6—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00509	0.0103	CbGpPWpGaD
Hydroxychloroquine—Hearing impaired—Capecitabine—esophageal cancer	0.00506	0.0112	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CAPZA1—esophageal cancer	0.00506	0.0102	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RNF6—esophageal cancer	0.00506	0.0102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR4—esophageal cancer	0.00496	0.01	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—esophageal cancer	0.0049	0.00992	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TLR4—esophageal cancer	0.00485	0.0098	CbGpPWpGaD
Hydroxychloroquine—Quinacrine—ABCB1—esophageal cancer	0.00483	0.0894	CrCbGaD
Hydroxychloroquine—Irritability—Cisplatin—esophageal cancer	0.00453	0.01	CcSEcCtD
Hydroxychloroquine—Chloroquine—ABCB1—esophageal cancer	0.00428	0.0793	CrCbGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CASP8—esophageal cancer	0.00426	0.00862	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CASP8—esophageal cancer	0.00421	0.00851	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—CASP8—esophageal cancer	0.00416	0.00841	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.0041	0.0083	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—ELMO1—esophageal cancer	0.00403	0.00816	CbGpPWpGaD
Hydroxychloroquine—Hepatic function abnormal—Capecitabine—esophageal cancer	0.004	0.00886	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TMEM173—esophageal cancer	0.004	0.00809	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CAPZA1—esophageal cancer	0.004	0.00809	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RNF6—esophageal cancer	0.004	0.00809	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity—Capecitabine—esophageal cancer	0.00398	0.00881	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Methotrexate—esophageal cancer	0.00397	0.00879	CcSEcCtD
Hydroxychloroquine—Deafness—Capecitabine—esophageal cancer	0.00391	0.00865	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Cisplatin—esophageal cancer	0.00389	0.00862	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR4—esophageal cancer	0.00387	0.00784	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TLR4—esophageal cancer	0.00383	0.00775	CbGpPWpGaD
Hydroxychloroquine—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00371	0.0082	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Capecitabine—esophageal cancer	0.00366	0.0081	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CFL1—esophageal cancer	0.00364	0.00736	CbGpPWpGaD
Hydroxychloroquine—Cardiac failure—Capecitabine—esophageal cancer	0.00358	0.00793	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—LGALS3—esophageal cancer	0.00349	0.00705	CbGpPWpGaD
Hydroxychloroquine—Aplastic anaemia—Methotrexate—esophageal cancer	0.00337	0.00745	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—MAP3K3—esophageal cancer	0.00335	0.00678	CbGpPWpGaD
Hydroxychloroquine—Irritability—Capecitabine—esophageal cancer	0.00334	0.00739	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CASP8—esophageal cancer	0.00332	0.00673	CbGpPWpGaD
Hydroxychloroquine—Mood swings—Capecitabine—esophageal cancer	0.00331	0.00733	CcSEcCtD
Hydroxychloroquine—Ataxia—Capecitabine—esophageal cancer	0.00329	0.00728	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—CASP8—esophageal cancer	0.00329	0.00665	CbGpPWpGaD
Hydroxychloroquine—Liver function test abnormal—Capecitabine—esophageal cancer	0.00323	0.00715	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Capecitabine—esophageal cancer	0.00319	0.00707	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—ELMO1—esophageal cancer	0.00319	0.00645	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00317	0.00641	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Cisplatin—esophageal cancer	0.00316	0.007	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TMEM173—esophageal cancer	0.00316	0.00639	CbGpPWpGaD
Hydroxychloroquine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00315	0.00697	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ACTB—esophageal cancer	0.00309	0.00626	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00308	0.00624	CbGpPWpGaD
Hydroxychloroquine—Muscular weakness—Capecitabine—esophageal cancer	0.00308	0.00683	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00307	0.00621	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Cisplatin—esophageal cancer	0.00307	0.00679	CcSEcCtD
Hydroxychloroquine—Tinnitus—Cisplatin—esophageal cancer	0.00306	0.00677	CcSEcCtD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00304	0.00616	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—B2M—esophageal cancer	0.00299	0.00605	CbGpPWpGaD
Hydroxychloroquine—Bronchospasm—Capecitabine—esophageal cancer	0.00297	0.00658	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Methotrexate—esophageal cancer	0.00296	0.00656	CcSEcCtD
Hydroxychloroquine—TLR9—PI3K Cascade—PIK3CA—esophageal cancer	0.00295	0.00598	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Cisplatin—esophageal cancer	0.0029	0.00642	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CFL1—esophageal cancer	0.00288	0.00582	CbGpPWpGaD
Hydroxychloroquine—Pancytopenia—Capecitabine—esophageal cancer	0.00287	0.00635	CcSEcCtD
Hydroxychloroquine—Malnutrition—Cisplatin—esophageal cancer	0.00286	0.00632	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CTSC—esophageal cancer	0.00285	0.00576	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GDI2—esophageal cancer	0.00283	0.00572	CbGpPWpGaD
Hydroxychloroquine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00276	0.00611	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00276	0.00611	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—LGALS3—esophageal cancer	0.00276	0.00557	CbGpPWpGaD
Hydroxychloroquine—Visual disturbance—Methotrexate—esophageal cancer	0.00275	0.00608	CcSEcCtD
Hydroxychloroquine—Weight decreased—Capecitabine—esophageal cancer	0.00273	0.00605	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—esophageal cancer	0.0027	0.00547	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Cisplatin—esophageal cancer	0.00269	0.00596	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00269	0.00544	CbGpPWpGaD
Hydroxychloroquine—Depression—Capecitabine—esophageal cancer	0.00269	0.00595	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00267	0.00591	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—MAP3K3—esophageal cancer	0.00265	0.00536	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Cisplatin—esophageal cancer	0.00264	0.00584	CcSEcCtD
Hydroxychloroquine—Leukopenia—Cisplatin—esophageal cancer	0.00256	0.00566	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Capecitabine—esophageal cancer	0.00251	0.00557	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—HMGB1—esophageal cancer	0.0025	0.00507	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.0025	0.00506	CbGpPWpGaD
Hydroxychloroquine—Irritability—Methotrexate—esophageal cancer	0.00248	0.0055	CcSEcCtD
Hydroxychloroquine—Convulsion—Cisplatin—esophageal cancer	0.00247	0.00548	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CA—esophageal cancer	0.00247	0.005	CbGpPWpGaD
Hydroxychloroquine—Mood swings—Methotrexate—esophageal cancer	0.00247	0.00546	CcSEcCtD
Hydroxychloroquine—Ataxia—Methotrexate—esophageal cancer	0.00245	0.00542	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—ACTB—esophageal cancer	0.00245	0.00495	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Capecitabine—esophageal cancer	0.00243	0.00538	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Capecitabine—esophageal cancer	0.00242	0.00535	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00241	0.00535	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CA—esophageal cancer	0.0024	0.00486	CbGpPWpGaD
Hydroxychloroquine—Liver function test abnormal—Methotrexate—esophageal cancer	0.0024	0.00532	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CA—esophageal cancer	0.00238	0.00482	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—B2M—esophageal cancer	0.00236	0.00478	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ELMO1—esophageal cancer	0.00235	0.00475	CbGpPWpGaD
Hydroxychloroquine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00234	0.00519	CcSEcCtD
Hydroxychloroquine—Oedema—Cisplatin—esophageal cancer	0.00233	0.00516	CcSEcCtD
Hydroxychloroquine—Visual impairment—Capecitabine—esophageal cancer	0.00233	0.00516	CcSEcCtD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CA—esophageal cancer	0.00232	0.00469	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CA—esophageal cancer	0.00232	0.00469	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Capecitabine—esophageal cancer	0.00229	0.00506	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Cisplatin—esophageal cancer	0.00229	0.00506	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00228	0.00505	CcSEcCtD
Hydroxychloroquine—Skin disorder—Cisplatin—esophageal cancer	0.00226	0.00501	CcSEcCtD
Hydroxychloroquine—Eye disorder—Capecitabine—esophageal cancer	0.00226	0.005	CcSEcCtD
Hydroxychloroquine—Tinnitus—Capecitabine—esophageal cancer	0.00226	0.00499	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CTSC—esophageal cancer	0.00225	0.00456	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Methotrexate—esophageal cancer	0.00223	0.00493	CcSEcCtD
Hydroxychloroquine—Anorexia—Cisplatin—esophageal cancer	0.00222	0.00492	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.0022	0.00445	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00217	0.00439	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Capecitabine—esophageal cancer	0.00214	0.00473	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Methotrexate—esophageal cancer	0.00214	0.00473	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CA—esophageal cancer	0.00214	0.00432	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CFL1—esophageal cancer	0.00212	0.00429	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Capecitabine—esophageal cancer	0.00212	0.00469	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—esophageal cancer	0.00211	0.00427	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Capecitabine—esophageal cancer	0.00211	0.00466	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ABL1—esophageal cancer	0.00207	0.00419	CbGpPWpGaD
Hydroxychloroquine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00205	0.00455	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—KMT2D—esophageal cancer	0.00204	0.00413	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—LGALS3—esophageal cancer	0.00203	0.00411	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Cisplatin—esophageal cancer	0.00203	0.00449	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00201	0.00446	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methotrexate—esophageal cancer	0.00201	0.00444	CcSEcCtD
Hydroxychloroquine—Depression—Methotrexate—esophageal cancer	0.002	0.00443	CcSEcCtD
Hydroxychloroquine—Pain—Cisplatin—esophageal cancer	0.00199	0.00441	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00199	0.0044	CcSEcCtD
Hydroxychloroquine—Vision blurred—Capecitabine—esophageal cancer	0.00198	0.00439	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—HMGB1—esophageal cancer	0.00198	0.004	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Capecitabine—esophageal cancer	0.00195	0.00431	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CA—esophageal cancer	0.00193	0.0039	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00189	0.00383	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Capecitabine—esophageal cancer	0.00189	0.00419	CcSEcCtD
Hydroxychloroquine—Leukopenia—Capecitabine—esophageal cancer	0.00188	0.00417	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—esophageal cancer	0.00187	0.00414	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ELMO1—esophageal cancer	0.00186	0.00376	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Capecitabine—esophageal cancer	0.00185	0.0041	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Cisplatin—esophageal cancer	0.00184	0.00408	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—ADCYAP1—esophageal cancer	0.00182	0.00369	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Methotrexate—esophageal cancer	0.00181	0.00401	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ACTB—esophageal cancer	0.0018	0.00365	CbGpPWpGaD
Hydroxychloroquine—Haemorrhage—Methotrexate—esophageal cancer	0.0018	0.00399	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00178	0.0036	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00178	0.00394	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00177	0.00358	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PTPN2—esophageal cancer	0.00176	0.00356	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00175	0.00354	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—B2M—esophageal cancer	0.00174	0.00352	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Methotrexate—esophageal cancer	0.00174	0.00384	CcSEcCtD
Hydroxychloroquine—Oedema—Capecitabine—esophageal cancer	0.00172	0.0038	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Cisplatin—esophageal cancer	0.00172	0.0038	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—esophageal cancer	0.0017	0.00377	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00169	0.00342	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Capecitabine—esophageal cancer	0.00169	0.00373	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—esophageal cancer	0.00168	0.00373	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00168	0.00372	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—esophageal cancer	0.00168	0.00372	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CFL1—esophageal cancer	0.00168	0.00339	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Cisplatin—esophageal cancer	0.00167	0.0037	CcSEcCtD
Hydroxychloroquine—Skin disorder—Capecitabine—esophageal cancer	0.00167	0.0037	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CA—esophageal cancer	0.00167	0.00337	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—WWOX—esophageal cancer	0.00167	0.00337	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00167	0.00337	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PSME2—esophageal cancer	0.00164	0.00333	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PSME1—esophageal cancer	0.00164	0.00333	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00164	0.00333	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Capecitabine—esophageal cancer	0.00164	0.00363	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—ABL1—esophageal cancer	0.00164	0.00331	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.00163	0.0033	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HSPA5—esophageal cancer	0.00163	0.0033	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—LGALS3—esophageal cancer	0.0016	0.00325	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Cisplatin—esophageal cancer	0.00159	0.00353	CcSEcCtD
Hydroxychloroquine—Alopecia—Methotrexate—esophageal cancer	0.00159	0.00352	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FKBP1A—esophageal cancer	0.00158	0.00321	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CALR—esophageal cancer	0.00158	0.00319	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Methotrexate—esophageal cancer	0.00158	0.00349	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TLR4—esophageal cancer	0.00157	0.00318	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Methotrexate—esophageal cancer	0.00157	0.00347	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—WIF1—esophageal cancer	0.00155	0.00313	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FBXW7—esophageal cancer	0.00153	0.00309	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Capecitabine—esophageal cancer	0.00149	0.00331	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00148	0.00328	CcSEcCtD
Hydroxychloroquine—Vomiting—Cisplatin—esophageal cancer	0.00148	0.00328	CcSEcCtD
Hydroxychloroquine—Fatigue—Capecitabine—esophageal cancer	0.00148	0.00328	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—esophageal cancer	0.00148	0.00327	CcSEcCtD
Hydroxychloroquine—Rash—Cisplatin—esophageal cancer	0.00147	0.00325	CcSEcCtD
Hydroxychloroquine—Pain—Capecitabine—esophageal cancer	0.00147	0.00325	CcSEcCtD
Hydroxychloroquine—Dermatitis—Cisplatin—esophageal cancer	0.00147	0.00325	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—HMGB1—esophageal cancer	0.00146	0.00295	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Methotrexate—esophageal cancer	0.00145	0.00321	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00144	0.00291	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CSNK1A1—esophageal cancer	0.00143	0.00289	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.00143	0.00289	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ACTB—esophageal cancer	0.00142	0.00288	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Methotrexate—esophageal cancer	0.00141	0.00312	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00141	0.00311	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—esophageal cancer	0.0014	0.00311	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PTPN2—esophageal cancer	0.00139	0.00281	CbGpPWpGaD
Hydroxychloroquine—Nausea—Cisplatin—esophageal cancer	0.00138	0.00307	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—B2M—esophageal cancer	0.00138	0.00278	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Capecitabine—esophageal cancer	0.00137	0.00302	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Capecitabine—esophageal cancer	0.00136	0.00301	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Capecitabine—esophageal cancer	0.00136	0.00301	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—esophageal cancer	0.00136	0.00301	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00135	0.00273	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CASP8—esophageal cancer	0.00135	0.00272	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CREBBP—esophageal cancer	0.00134	0.00271	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PFN1—esophageal cancer	0.00134	0.0027	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.00133	0.00269	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00133	0.00293	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00131	0.00265	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PSME1—esophageal cancer	0.0013	0.00263	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PSME2—esophageal cancer	0.0013	0.00263	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HSPA5—esophageal cancer	0.00129	0.0026	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Capecitabine—esophageal cancer	0.00127	0.0028	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—esophageal cancer	0.00125	0.00278	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—esophageal cancer	0.00125	0.00277	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CALR—esophageal cancer	0.00125	0.00252	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Methotrexate—esophageal cancer	0.00124	0.00275	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TLR4—esophageal cancer	0.00124	0.00251	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.00123	0.0025	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Capecitabine—esophageal cancer	0.00123	0.00273	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—esophageal cancer	0.00122	0.0027	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.00122	0.00246	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Capecitabine—esophageal cancer	0.00122	0.00269	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—ABL1—esophageal cancer	0.00121	0.00244	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FBXW7—esophageal cancer	0.00121	0.00244	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ELMO1—esophageal cancer	0.0012	0.00243	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Capecitabine—esophageal cancer	0.00118	0.0026	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—AKAP13—esophageal cancer	0.00117	0.00237	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—BCL2—esophageal cancer	0.00116	0.00234	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HMGB1—esophageal cancer	0.00115	0.00233	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Methotrexate—esophageal cancer	0.00114	0.00252	CcSEcCtD
Hydroxychloroquine—Dizziness—Capecitabine—esophageal cancer	0.00114	0.00252	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ERBB2—esophageal cancer	0.00112	0.00227	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Methotrexate—esophageal cancer	0.00111	0.00246	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.0011	0.00244	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—esophageal cancer	0.0011	0.00244	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—esophageal cancer	0.00109	0.00242	CcSEcCtD
Hydroxychloroquine—Vomiting—Capecitabine—esophageal cancer	0.00109	0.00242	CcSEcCtD
Hydroxychloroquine—Rash—Capecitabine—esophageal cancer	0.00108	0.0024	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00108	0.00219	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Capecitabine—esophageal cancer	0.00108	0.0024	CcSEcCtD
Hydroxychloroquine—Headache—Capecitabine—esophageal cancer	0.00108	0.00238	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PDE4D—esophageal cancer	0.00107	0.00217	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CASP8—esophageal cancer	0.00106	0.00215	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CREBBP—esophageal cancer	0.00106	0.00214	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00105	0.00232	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—GNG7—esophageal cancer	0.00102	0.00207	CbGpPWpGaD
Hydroxychloroquine—Nausea—Capecitabine—esophageal cancer	0.00102	0.00226	CcSEcCtD
Hydroxychloroquine—Urticaria—Methotrexate—esophageal cancer	0.00102	0.00225	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—esophageal cancer	0.00101	0.00224	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—esophageal cancer	0.00101	0.00224	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.00101	0.00204	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CDKN1A—esophageal cancer	0.00096	0.00194	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000957	0.00194	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—XIAP—esophageal cancer	0.000957	0.00194	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ABL1—esophageal cancer	0.000954	0.00193	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000946	0.00191	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Methotrexate—esophageal cancer	0.000942	0.00209	CcSEcCtD
Hydroxychloroquine—Asthenia—Methotrexate—esophageal cancer	0.000918	0.00203	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TLR4—esophageal cancer	0.000914	0.00185	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—BCL2—esophageal cancer	0.000914	0.00185	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EP300—esophageal cancer	0.000913	0.00185	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Methotrexate—esophageal cancer	0.000905	0.002	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNA1—esophageal cancer	0.000905	0.00183	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL2—esophageal cancer	0.0009	0.00182	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000897	0.00181	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ERBB2—esophageal cancer	0.000888	0.0018	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Methotrexate—esophageal cancer	0.000875	0.00194	CcSEcCtD
Hydroxychloroquine—Dizziness—Methotrexate—esophageal cancer	0.000846	0.00187	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PSME2—esophageal cancer	0.00084	0.0017	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PSME1—esophageal cancer	0.00084	0.0017	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ANXA1—esophageal cancer	0.000836	0.00169	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SST—esophageal cancer	0.000814	0.00165	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Methotrexate—esophageal cancer	0.000813	0.0018	CcSEcCtD
Hydroxychloroquine—Rash—Methotrexate—esophageal cancer	0.000807	0.00179	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—esophageal cancer	0.000806	0.00178	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—esophageal cancer	0.000801	0.00177	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—GHRL—esophageal cancer	0.000793	0.0016	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH3—esophageal cancer	0.000793	0.0016	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CASP8—esophageal cancer	0.000784	0.00159	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CREBBP—esophageal cancer	0.000781	0.00158	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FBXW7—esophageal cancer	0.00078	0.00158	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—EGFR—esophageal cancer	0.000778	0.00157	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000763	0.00154	CbGpPWpGaD
Hydroxychloroquine—Nausea—Methotrexate—esophageal cancer	0.00076	0.00168	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—CDKN1A—esophageal cancer	0.000759	0.00153	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000752	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TLR4—esophageal cancer	0.000723	0.00146	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EP300—esophageal cancer	0.000722	0.00146	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000717	0.00145	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH2—esophageal cancer	0.000711	0.00144	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000707	0.00143	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—esophageal cancer	0.000675	0.00137	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BCL2—esophageal cancer	0.000673	0.00136	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERBB2—esophageal cancer	0.000654	0.00132	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFBR2—esophageal cancer	0.000631	0.00128	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CASP8—esophageal cancer	0.00062	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CREBBP—esophageal cancer	0.000617	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—esophageal cancer	0.000615	0.00124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SMAD4—esophageal cancer	0.000597	0.00121	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CDKN1A—esophageal cancer	0.000559	0.00113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—esophageal cancer	0.000534	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2—esophageal cancer	0.000532	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EP300—esophageal cancer	0.000532	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ERBB2—esophageal cancer	0.000517	0.00105	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HIF1A—esophageal cancer	0.000489	0.000988	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KDR—esophageal cancer	0.000467	0.000945	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—esophageal cancer	0.000453	0.000917	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDKN1A—esophageal cancer	0.000442	0.000894	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH1—esophageal cancer	0.00044	0.000891	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EP300—esophageal cancer	0.00042	0.000851	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CREBBP—esophageal cancer	0.000399	0.000807	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—esophageal cancer	0.000393	0.000796	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000385	0.00078	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000385	0.00078	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—esophageal cancer	0.000358	0.000725	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOS3—esophageal cancer	0.000357	0.000723	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB2—esophageal cancer	0.000334	0.000676	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000328	0.000663	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CA1—esophageal cancer	0.000328	0.000663	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—esophageal cancer	0.000311	0.000629	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CA2—esophageal cancer	0.0003	0.000606	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—esophageal cancer	0.000295	0.000597	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CDKN1A—esophageal cancer	0.000286	0.000578	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000279	0.000564	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000279	0.000564	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EP300—esophageal cancer	0.000272	0.00055	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000244	0.000494	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—esophageal cancer	0.000237	0.000479	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000233	0.000472	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—esophageal cancer	0.000232	0.000469	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000227	0.00046	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000221	0.000448	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000211	0.000427	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000211	0.000427	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000202	0.00041	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—esophageal cancer	0.000201	0.000407	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000195	0.000394	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—esophageal cancer	0.000195	0.000394	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000193	0.000391	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000184	0.000372	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000172	0.000348	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000164	0.000331	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000162	0.000327	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000153	0.00031	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000153	0.00031	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PSME2—esophageal cancer	0.000151	0.000306	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PSME1—esophageal cancer	0.000151	0.000306	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	0.00013	0.000264	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	0.000123	0.000248	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMOX1—esophageal cancer	0.000112	0.000226	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ABCB1—esophageal cancer	0.000107	0.000217	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.18e-05	0.000145	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NOS3—esophageal cancer	6.43e-05	0.00013	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—esophageal cancer	5.88e-05	0.000119	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—EP300—esophageal cancer	4.89e-05	9.89e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.62e-05	7.32e-05	CbGpPWpGaD
